HIF-1-dependent reprogramming of glucose metabolic pathway of cancer cells and its therapeutic significance

A Nagao, M Kobayashi, S Koyasu, CCT Chow… - International journal of …, 2019 - mdpi.com
… in cancer cells, suggesting the association of HIF-1-mediated … to cancer cell-specific gene
mutations or an aberrant gene … of isocitrate dehydrogenase 3 (IDH3), IDH3α [37], or mutations …

Wild-type IDH enzymes as actionable targets for cancer therapy

E Bergaggio, R Piva - Cancers, 2019 - mdpi.com
… on aberrant IDH1, IDH2, and IDH3 expressions in cancers. … IDH3α-mediated
promotion of tumor growth and IDH3α silencing delays tumorigenesis by suppressing HIF-1-mediated

IDH3α regulates one-carbon metabolism in glioblastoma

JL May, FM Kouri, LA Hurley, J Liu… - Science …, 2019 - science.org
… –induced extramitochondrial IDH3α, we defined the IDH3α interactome using IP-MS studies
in patient-derived GICs, expressing a scrambled or an IDH3α-… Aberrant expression of IDH3α

Cancer-associated mutation and beyond: The emerging biology of isocitrate dehydrogenases in human disease

S Tommasini-Ghelfi, K Murnan, FM Kouri… - Science …, 2019 - science.org
… 124 of the human IDH3α polypeptide, IDH3α can localize to … resulting in aberrant amino acid
metabolism and acid buildup, … IDHs promote tumor development, while reduced expression

Mutant IDH in gliomas: Role in cancer and treatment options

G Solomou, A Finch, A Asghar, C Bardella - Cancers, 2023 - mdpi.com
… to promote cell transformation. The different consequences of IDH3α aberrant expression
for … by the diverse metabolic requirements of each tissue during malignant transformation. …

Wild-Type Isocitrate Dehydrogenase-Dependent Oxidative Decarboxylation and Reductive Carboxylation in Cancer and Their Clinical Significance

Q He, J Chen, Z Xie, Z Chen - Cancers, 2022 - mdpi.com
… dehydrogenases in metabolism, provide a current overview of cancer-… in microvessel density
and tumor growth, suggesting an … IDH3α promotes the upregulation of the expression of …

Inhibition of IDH3α Enhanced the Efficacy of Chemoimmunotherapy by Regulating Acidic Tumor Microenvironments

L Zhang, Y Song, X Dai, W Xu, M Li, Y Zhu - Cancers, 2023 - mdpi.com
… not clear whether the aberrant expression of IDH3α is related to … of IDH3α expression on
tumor growth after cisplatin treatment. … Overall, high expression of IDH3α promoted metabolic

Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity

M Cai, J Zhao, Q Ding, J Wei - Heliyon, 2024 - cell.com
aberrant metabolite found in tumor cells, exerting a pivotal influence on … in cancer
immunotherapy. This review delves into the metabolism, biological functions, and impacts on the …

A Molecular Perspective on HIF-1α and Angiogenic Stimulator Networks and Their Role in Solid Tumors: An Update

AG Magar, VK Morya, MK Kwak, JU Oh… - International Journal of …, 2024 - mdpi.com
… a metabolic shift towards aerobic glycolysis, even under normoxic conditions (Warburg effect)
[31]. This metabolic switch promotes tumor growth and … to aberrant angiogenesis in cancer

APC/C-CDH1–Regulated IDH3β Coordinates with the Cell Cycle to Promote Cell Proliferation

Q Wu, W Zhang, L Xue, Y Wang, M Fu, L Ma, Y Song… - Cancer research, 2019 - AACR
promoting G 1 –S transition and cell growth. However, previous study reported that IDH3α
induced HIF-1mediated metabolic … Because both IDH3α and IDH3β are the subunits of IDH3, …